Buscar resultados de ensayos clínicos

Patrocinado por

Juvenile Myelomonocytic Leukemia - 20 Studies Found

Estado Estudiar
Not yet recruiting Nombre del estudio: Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)
Condición:
  • Acute Leukemias
  • Chronic Leukemias
  • Myelodysplastic Syndrome
    Fecha: 2011-04-20
    Intervenciones: Drug: Busulfan/Cyclophosphamide Conditioning regimen:
Active, not recruiting Nombre del estudio: Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies
Condición:
  • Acute Lymphoblastic Leukaemias (ALL)
  • Acute Myeloid Leukaemias (AML)
  • Acute Lymphoblastic Leukemia
  • Chronic Myelogenous Leukemia

  • Fecha: 2008-04-14
    Intervenciones:
    • Other: NK Cell Infusion All pa
Recruiting Nombre del estudio: Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Condición:
  • Acute Lymphoblastic Leukemia/Lymphoma
  • Myelodysplasia
  • Acute
    Fecha: 2015-01-12
Completed Nombre del estudio: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
Condición:
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute, T-Cell
  • Procedure: Haploidentical donor derived natural killer cell infusion

Withdrawn Nombre del estudio: Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)
Condición:
  • Chronic Myelomonocytic Leukemia
  • Juvenile Myelomonocytic Leukemia Fecha: 2015-09-29
    Intervenciones:
    • Drug: Pacritinib -Patients sho
Completed Nombre del estudio: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Condición:
  • Chronic Myeloid Leukemia (CML)
  • Acute Myelogenous Leukemia (AML);
  • Device: CliniMACS CD34+ Reagent System

Terminated Nombre del estudio: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
Condición:
  • Acute Lymphoblastic Leukemia
  • Acute Myelocytic Leukemia
  • Chr
    Fecha: 2012-06-08
    Intervenciones:
    • Drug: clofarabine Given on Day
Completed Nombre del estudio: Stem Cell Transplantation for Patients With Hematologic Malignancies
Condición:
  • Acute Lymphoblastic Leukemias
  • Acute Myelocytic Leukemia
  • Ch
    Fecha: 2005-09-08
    Intervenciones:
    • Procedure: Allogeneic Stem Cell Transplantation

Completed Nombre del estudio: Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
Condición:
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukem
    Fecha: 2005-09-01
    Intervenciones:
    • Drug: Systematic chemotherapy and antibodies

<<< Previous